Projects we run
We are the beneficiaries of The National Center for Research and Development and the European Funds of Smart Growth!
Partnering with NanoVelos
Our chemists are looking forward to conjugating your drug with dextran nanoparticles and making it ready for preclinical trials. Please contact us to start collaborating!
We are planning to develop our proprietary system in conjugation with generics to give them a “second life” and the opportunity to be more specific and increase tumor targeting. We offer you a possibility to invest in this exciting project – please contact us to get more details.